Shares Magazine
37.25p+0.00 (+0.00%)30 Jun 2022, 15:39
Jump to:
Rua Life Sciences PLC Fundamentals
| Company Name | Rua Life Sciences PLC | Last Updated | 2022-06-30 |
|---|---|---|---|
| Industry | Medical Devices | Sector | Healthcare |
| Shares in Issue | 22.185 m | Market Cap | £8.26 m |
| PE Ratio | 0.00 | Dividend per Share | 0 |
| Dividend Yield | 0 | Dividend Cover | 0 |
| EPS | -£0.08 | EPS Growth (%) | 0 |
| PEG | 0 | DPS Growth (%) | 0 |
| Debt Ratio | 0.0425 | Debt Equity Ratio | 0.0427 |
| Asset Equity Ratio | 1.2233 | Cash Equity Ratio | 0.6558 |
| Quick Ratio | 5.9315 | Current Ratio | 6.12 |
| Price To Book Value | 1.1378 | ROCE | 0 |
Rua Life Sciences PLC Dividends
| Type | Ex-Date | Pay Date | Currency | Net Dividend | Year Total |
|---|
Rua Life Sciences PLC Company Financials
| Assets | 2021 | 2020 | 2019 |
|---|---|---|---|
| Tangible Assets | £1.95 m | £5,000.00 | £1,000.00 |
| Intangible Assets | £875,000.00 | £255,000.00 | £448,000.00 |
| Investments | 0 | 0 | 0 |
| Total Fixed Assets | £2.83 m | £260,000.00 | £449,000.00 |
| Stocks | £85,000.00 | 0 | 0 |
| Debtors | £481,427.00 | £225,919.00 | £238,000.00 |
| Cash & Equivalents | £6.29 m | £1.01 m | £2.41 m |
| Other Assets | 0 | 0 | 0 |
| Total Assets | £10.15 m | £2.49 m | £3.10 m |
| Liabilities | 2021 | 2020 | 2019 |
|---|---|---|---|
| Creditors within 1 year | £1.10 m | £219,000.00 | £99,000.00 |
| Creditors after 1 year | £550,000.00 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 |
| Total Liabilities | £1.65 m | £219,000.00 | £99,000.00 |
| Net assets | £8.51 m | £2.27 m | £3.00 m |
| Equity | 2021 | 2020 | 2019 |
|---|---|---|---|
| Called up share capital | £12.95 m | £12.57 m | £12.57 m |
| Share Premium | £11.73 m | £4.55 m | £4.55 m |
| Profit / Loss | -£1.59 m | -£897,000.00 | -£609,000.00 |
| Other Equity | £8.51 m | £2.27 m | £3.00 m |
| Preference & Minorities | 0 | 0 | 0 |
| Total Capital Employed | £8.51 m | £2.27 m | £3.00 m |
| Ratios | 2021 | 2020 | 2019 |
|---|---|---|---|
| Debt Ratio | £0.04 | 0 | 0 |
| Debt-to-Equity | £0.04 | 0 | 0 |
| Assets / Equity | 1.2233 | 1.2233 | 1.2233 |
| Cash / Equity | 0.6558 | 0.6558 | 0.6558 |
| EPS | -£0.08 | -£0.05 | -£0.05 |
| Cash Flow | 2021 | 2020 | 2019 |
|---|---|---|---|
| Cash from operating activities | -£1.41 m | -£438,000.00 | -£429,000.00 |
| Cashflow before financing | £5.27 m | -£438,000.00 | £2.12 m |
| Increase in Cash | £4.32 m | -£436,000.00 | £1.99 m |
| Income | 2021 | 2020 | 2019 |
|---|---|---|---|
| Turnover | £1.53 m | £489,000.00 | £463,000.00 |
| Cost of sales | £276,000.00 | 0 | 0 |
| Gross Profit | £1.25 m | £489,000.00 | 0 |
| Operating Profit | -£1.55 m | -£941,000.00 | -£638,000.00 |
| Pre-Tax profit | -£1.59 m | -£897,000.00 | -£609,000.00 |
Rua Life Sciences PLC Company Background
| Sector | Healthcare |
|---|---|
| Activities | RUA Life Sciences PLC is a biomedical polymer technology, components, and medical device company. The company's only operating segment; exploiting the value of its IP and know-how. Geographically, it derives most of the revenue from the USA and has a presence in Europe and the Rest of the world. It has developed biostable, implantable polymers, including technology such as Elast-Eon, Elast-Eon Carbonate Silicone, and Elast-Eon Reaction Injection Molding (RIM) technology. Also, the company has developed a range of large bore vascular grafts. The company earns its revenues in the form of royalties and license fees. |
| Latest Interim Date | 16 Dec 2021 |
| Latest Fiscal Year End Date | 15 Jul 2022 |
Rua Life Sciences PLC Directors
| Appointed | Name | Position |
|---|---|---|
| 2020-12-11 | Mr. James Gordon Wright | Non-Executive Director |
| 2013-12-03 | Mr. Francis Patrick Maguire | Executive Director,Chief Executive |
| 2012-12-31 | Mr. Jonathan Peter Pither | Non-Executive Director |
| 2016-10-31 | Mr. Edward Eddie McDaid | Executive Director,Chief Executive Officer |
| 2021-07-28 | Mr. William Donald Brown | Executive Director,Chairman |
| 2011-10-21 | Dr. Stuart Bernard Rollason | Non-Executive Director |
| 2015-06-01 | Mr. Roy Walter Mitchell | Non-Executive Director,Finance Director |
| 2021-07-28 | Mr. John McKenna | Executive Director,Director of Clinical Marketing |
| 2021-07-28 | Mr. John Louis Ely | Non-Executive Director |
| 2021-07-28 | Mr. Geoffrey Alan Berg | Non-Executive Director |
| 2021-08-10 | Mr. David Muir Richmond | Executive Director,Chief Executive Officer |
| 2021-02-05 | Dr. Caroline Stretton | Executive Director,Managing Director |
Rua Life Sciences PLC Contact Details
| Company Name | RUA Life Sciences PLC |
|---|---|
| Address | c/o Kergan Stewart LLP, 163 Bath Street, Glasgow, G2 4SQ |
| Telephone | |
| Website | https://www.rualifesciences.com |
Rua Life Sciences PLC Advisors
| Registrar | Equiniti Limited |
|---|
| Stockbroker | FinnCap |
|---|---|
| Phone | +44 2072200500 |
| Fax | +44 2076001659 |
| Auditor | Grant Thornton UK LLP |
|---|---|
| Phone | (0116) 247 1234 |
| Fax | (0116) 247 1434 |
| Solicitor | DAC Beachcroft LLP |
|---|---|
| Phone | +44 2072421011 |
| Fax | +44 2078316630 |
| Solicitor | Brodies LLP |
|---|---|
| Phone | (0131) 228 3777 |
| Fax | (0131) 228 3878 |
| Bank | Bank of Scotland |
|---|
| Nominated Adviser | FinnCap |
|---|---|
| Phone | +44 2072200500 |
| Fax | +44 2076001659 |
Sign up to our
daily email
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
Plus more useful investment content and occasional promotional offers.
Market Overview
UK 350 Risers and Fallers
Risers
| Company | Price | % Chg |
|---|---|---|
| Discoverie Group PLC | 660.00 | 6.45 |
| Carnival PLC | 656.80 | 6.00 |
| Wizz Air Holdings PLC | 1,858.50 | 5.96 |
| Helios Towers PLC | 128.00 | 5.87 |
| Asos PLC | 882.00 | 5.19 |
| Ocado Group PLC | 814.00 | 4.20 |
Fallers
| Company | Price | % Chg |
|---|---|---|
| Harbour Energy PLC | 332.60 | -8.58 |
| Chrysalis Investments Limited | 96.20 | -7.68 |
| Tullow Oil PLC | 43.52 | -7.13 |
| Hg Capital Trust PLC | 315.00 | -4.69 |
| Energean PLC | 1,048.00 | -4.64 |
| Plus500 LTD | 1,596.00 | -4.60 |
